We are thrilled to announce the approval of Zendia GmbH’s USA Patent WO2018002327 titled “Rapid Test for Detecting Pathogens and…
Zendia Targets Market Entry with Innovative Malaria Diagnostic Solution
Zendia GmbH is aiming to enter the market bolstered by a substantial grant of 290,000 Euros from the German Federal…
ZENDIA CONDUCTS SECOND INFECTOTEST® FEASIBILITY STUDY IN KYENJOJO, UGANDA
Together with Dr Gerald Tumussime and his team in Uganda, Zendia GmbH goes back to the district of Kyenjojo to…
Begins Testing Phase with Lyophilized Reagents from EVIK Diagnostics
Zendia GmbH received its first batch of lyophilized reagent beads from EVIK Diagnostics, Kanata, Canada. This acquisition marks the start…
Joint Venture with Charité Universitätsmedizin & Berlin Johann Wolfgang Goethe University
InfectoTest® collaboration team received a positive answer from the ethics committee from Berlin and Frankfurt for the study protocol “Entwicklung…
Zendia Embarks on First InfectoTest® Feasibility Study in Kampala, Uganda
Zendia GmbH proudly launched its first field feasibility study, a collaboration with the medical faculty at Ugandan Christian University Under…